A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Using FoundationOne Liquid, a novel liquid biopsy test providing targeted gene and microsatellite instability-high results, researchers sought to examine whether specific biomarkers contribute to TNBC ...

Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Circana, LLC today announced the launch of Liquid Testing™, an AI-powered, self-serve tool that gives consumer packaged goods and general merchandise ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...

Biopsies are a necessary burden for people with cancer. Taking a small sample of tissue and sending it through genetic and molecular analysis can help doctors not just diagnose cancer, but also learn ...

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...

England's health system said it will roll out new cancer testing known as liquid biopsy, first to 15,000 lung cancer patients, then to many others. Experts say the technology is revolutionary because ...

insights from industryErik GublerProduct ManagerMettler-Toledo GmbH In this interview, AZoM speaks to Erik Gubler, Product Manager at Mettler-Toledo GmbH, about e-liquid testing; how to do it, why it ...

Liquid biopsies may be less invasive and faster in determining the genetics of a tumor — and with high accuracy — among those diagnosed with non-small cell lung cancer. Researchers believe ...

A new liquid biopsy test could detect microsatellite instability and tumor mutational burden, which can distinguish which patients are likely to respond to immune checkpoint inhibitors. A liquid ...